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Abstract
Objective To investigate and quantify the potential dose-response
association between egg consumption and risk of coronary heart disease
and stroke.
Design Dose-response meta-analysis of prospective cohort studies.
Data sources PubMed and Embase prior to June 2012 and references
of relevant original papers and review articles.
Eligibility criteria for selecting studies Prospective cohort studies
with relative risks and 95% confidence intervals of coronary heart disease
or stroke for three or more categories of egg consumption.
Results Eight articles with 17 reports (nine for coronary heart disease,
eight for stroke) were eligible for inclusion in the meta-analysis (3 081
269 person years and 5847 incident cases for coronary heart disease,
and 4 148 095 person years and 7579 incident cases for stroke). No
evidence of a curve linear association was seen between egg
consumption and risk of coronary heart disease or stroke (P=0.67 and
P=0.27 for non-linearity, respectively). The summary relative risk of
coronary heart disease for an increase of one egg consumed per day
was 0.99 (95% confidence interval 0.85 to 1.15; P=0.88 for linear trend)
without heterogeneity among studies (P=0.97, I
2=0%). For stroke, the
combined relative risk for an increase of one egg consumed per day
was 0.91 (0.81 to 1.02; P=0.10 for linear trend) without heterogeneity
among studies (P=0.46, I
2=0%). In a subgroup analysis of diabetic
populations, the relative risk of coronary heart disease comparing the
highest with the lowest egg consumption was 1.54 (1.14 to 2.09; P=0.01).
In addition, people with higher egg consumption had a 25% (0.57 to
0.99; P=0.04) lower risk of developing hemorrhagic stroke.
Conclusions Higher consumption of eggs (up to one egg per day) is
not associated with increased risk of coronary heart disease or stroke.
The increased risk of coronary heart disease among diabetic patients
and reduced risk of hemorrhagic stroke associated with higher egg
consumption in subgroup analyses warrant further studies.
Introduction
Cardiovascular disease is now a public health crisis, affecting
millions of people in both developed and developing countries.
Althoughtherateofdeathattributabletothediseasehasdeclined
in developed countries in the past several decades, it is still the
leading cause of death and extorts a heavy social and economic
toll globally.
1-3 In low and middle income countries, the
prevalenceofcardiovasculardiseasehasincreaseddramatically.
By 2020, the disease is forecasted to be the major cause of
morbidity and mortality in most developing nations.
4
In recent decades, concern has mounted regarding the high
prevalence and costs associated with cardiovascular disease,
with growing interest in altering risk factors and reversing this
global epidemic. Among the known risk factors for
cardiovascular disease, levels of low density lipoprotein (LDL)
cholesterol have aroused particular attention. In the Women’s
HealthStudy,afterameanfollow-upofeightyears,participants
with the highest levels of LDL cholesterol showed a notably
higher risk of cardiovascular events than those with the lowest
levels.
5 In addition, several meta-analyses of observational
studies and randomized controlled trials have found that a
reduction in concentrations of LDL cholesterol could
significantlyreducetheriskofcoronaryheartdiseaseandstroke
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Research
RESEARCHincidence and mortality.
6-9 Diet is an important determinant of
serum cholesterol, but dietary cholesterol has only a modest
contribution to plasma concentrations of LDL cholesterol.
10 On
the other hand, dietary cholesterol may prompt the oxidation of
LDL and increase postprandial lipemia, which could raise the
risk of vascular disease.
11 To minimize the elevation of blood
cholesterol and reduce the risk of cardiovascular disease, the
American Heart Association (AHA) has recommended the
public to consume less than 300 mg/day of cholesterol.
12 13
Since eggs are a major source of dietary cholesterol, with one
large egg containing almost 210 mg of cholesterol, the public
has been recommended to limit egg consumption unless the
intakeofotherfoodshighincholesterolisrestricted.
14However,
eggs are also an inexpensive and low calorie source of many
other nutrients, including minerals, proteins, and unsaturated
fatty acids, which could lower the risk of cardiovascular
disease.
15Additionally,inpopulationsfollowingacarbohydrate
restricted diet, dietary cholesterol from eggs could increase
plasma concentrations of high density lipoprotein (HDL)
cholesterol,
16 which has been suggested to protect against
vascular disease.
17 18 Therefore, some organizations have
recommended that reducing egg intake might not be important
for healthy people with normal levels of cholesterol in the
blood.
19Foodbaseddietaryguidelinesfromcountriesincluding
Nepal,Thailand,andSouthAfricarecommendconsumingeggs
every day or regularly as part of a healthy diet.
20
Severalprospectivecohortstudieshaveexaminedtheassociation
between egg consumption and risk of coronary heart disease
and stroke. However, the relation between egg consumption
and risk of cardiovascular disease remains controversial.
Therefore, we conducted a dose-response meta-analysis of
prospective cohort studies to quantify the association between
egg consumption and risk of coronary heart disease and stroke.
Methods
Search strategy
We conducted a literature search of PubMed (Medline) and
Embase from January 1966 through June 2012 for prospective
cohort studies examining the association between egg
consumptionandriskofCHDandstroke.PubMedsearchterms
were“CardiovascularDiseases”[MeSH]or“Stroke”[MeSH]or
“CoronaryDisease”[MeSH]or“myocardialinfarction”[MeSH]
or CHD) and egg. Similar search terms were used for Embase.
In addition, we scrutinized references from relevant original
papers and review articles to identify further pertinent studies.
No language restrictions were imposed. We followed the
standard criteria for conducting meta-analyses of observational
studies and reporting the results.
21
Study selection
Studies were included in this meta-analysis if they satisfied the
following criteria: the study design was prospective, the
exposure of interest was egg consumption, the outcome was
coronary heart disease or stroke, and the investigators reported
relative risks with 95% confidence intervals for at least three
quantitativecategoriesofeggintake.Additionally,weexcluded
reviews, editorials, non-human studies, and letters without
sufficient data. Studies of other exposures and diseases were
also excluded. If study populations were reported more than
once, we used the result with the longest follow-up time.
Data extraction
Data extraction was carried out independently by two authors
(YR and LC) using a standard extraction form. We extracted
the following information from each study: authors, year of
publication, study name, study location, years of follow-up,
sample size (number of participants and incident cases),
participants’ characteristics (age and sex), endpoints (coronary
heart disease, stroke, or both), outcomes ascertainment, egg
consumptioncategories,covariatesadjustedinthemultivariable
analysis, and relative risks (95% confidence intervals) for all
categories of egg consumption.
Quality assessment was performed according to the
Newcastle-Ottawa quality assessment scale,
22 which is a
validated scale for non-randomised studies in meta-analyses.
Thisscaleawardsamaximumofninepointstoeachstudy:four
for selection of participants and measurement of exposure, two
for comparability of cohorts on the basis of the design or
analysis, and three for assessment of outcomes and adequacy
of follow-up. We assigned scores of 0-3, 3.5-6, and 6.5-9 for
low, moderate, and high quality of studies, respectively. When
studies had several adjustment models, we extracted those that
reflected the maximum extent of adjustment for potentially
confounding variables.
Forstudiesthatreportedeggintakeasservingsperweekorday,
we assumed that each serving was equivalent to one egg. For
studies that lacked the unit of consumption, the categories were
estimated by multiplying the frequency of consumption from
the food frequency questionnaires with an average portion size
according to the mean intake derived from the 24 h diaries. We
contacted the authors if the data of interest were not directly
shown in the publications. To resolve discrepancies, we used
group consensus and consulted a third reviewer.
Statistical analysis
In this meta-analysis, the relative risks and 95% confidence
intervals were considered as the effect size for all studies, and
the hazard ratios were deemed equivalent to relative risks. Any
results stratified by sex were treated as two separate reports.
Those articles reporting both coronary heart disease and stroke
were also treated as two separate reports. Owing to the distinct
cut-off points for categories in different articles, we computed
a relative risk with 95% confidence interval for an increased
intakeofoneeggperdayforeachreport.Themethoddescribed
byGreenlandandLongnecker
23andOrsiniandcolleagues
24was
used to calculate the trend from the correlated estimates for log
relative risk across categories of egg consumption. The amount
of egg consumption, distributions of cases and person years,
and relative risks and 95% confidence intervals were extracted
according to this method.
The median or mean egg consumption in each category was
used as the corresponding dose of consumption. The midpoint
of the upper and lower boundaries was considered the dose of
each category if the median or mean intake per category was
not available. If the highest category was open ended, the
midpoint of the category was set at 1.5 times the lower
boundary. If the number of cases and person years were not
available,weusedtherelativeriskscomparingthehighestversus
lowest categories of egg intake to obtain a summary estimate.
In addition, we evaluated a potential curve linear association
between egg consumption and risk of coronary heart disease
and stroke, using restricted cubic splines with three knots at
percentiles 10%, 50%, and 90% of the distribution.
25 A P value
forcurvelinearityornon-linearitywascalculatedbytestingthe
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RESEARCHnull hypothesis that the coefficient of the second spline is equal
to zero.
TheheterogeneityamongstudieswasestimatedbytheCochran
Q test and I
2 statistic.
26 Heterogeneity was confirmed with a
significance level of P≤0.10. The I
2 statistic describes the
percentage of total variation in point estimates that can be
attributed to heterogeneity. For the I
2 metric, we considered
low, moderate, and high I
2 values to be 25%, 50%, and 75%,
respectively.
26 27Weusedafixedeffectmodel(Mantel-Haenszel
method)whenheterogeneitywasnegligible,andarandomeffect
model (DerSimonian and Laird method) when heterogeneity
was significant.
28 Forest plots and funnel plots were used to
examine the overall effect and assess the publication bias,
respectively.
We also conducted analyses stratified by sex, study location,
numberofcasesandparticipants,durationoffollow-up,repeated
egg consumption measurements, study quality, and whether
dietvariablesorcholesterollevelswerecontrolledforinmodels.
All statistical analyses were performed with Stata version 11
(Stata Corp), and all tests were two sided with a significance
level of 0.05.
Results
Literature search
Figure 1⇓ shows the results of literature research and selection.
We identified 616 articles from PubMed and 824 articles from
Embase prior to 20 June 2012. After exclusion of duplicates
andstudiesthatdidnotfulfilltheinclusioncriteria,16remaining
articles seemed to be relevant for this meta-analysis. After
evaluating the full texts of these 16 publications, we excluded
eight articles as follows. Two articles
29 30 were excluded owing
tolackofsufficientdataforestimationofrelativerisks.Another
two articles
31 32 were excluded because they did not separately
report the relative risks and 95% confidence intervals for
coronary heart disease or stroke. We also excluded one report
33
because it was the meeting abstract of the study by Scrafford
and colleagues.
34 A study by He and colleagues
35 was excluded
because it reported the intermediate follow-up results of Health
ProfessionalsFollow-upStudy.Thefinalmeta-analysisincluded
eight articles, of which four
34 36-38 examined men and women
separately. For the study by Scrafford and colleagues,
34 the
estimateoftheassociationbetweeneggconsumptionandstroke
mortalityamongmenwasimprecisebecauseofsparsedata,and
thus for this report we included only data for women. In total,
our meta-analysis included eight articles with 17 independent
reports.
Study characteristics
Tables 1⇓ and 2⇓ show the information extracted from the
included studies, all of which had prospective cohort designs
and participants with no prior diagnoses of cardiovascular
disease at baseline. The meta-analysis consisted of 263 938
participants with 3 081 269 person years of follow-up for
coronary heart disease, and 210 404 patients with 4 148 095
person years of follow-up for stroke. Among the participants,
we documented 5847 cases of coronary heart disease during
follow-up periods ranging from eight to 20 years, and 7579
casesofstrokeduringafollow-uprangingfrom8.8to22years.
Three cohorts
37 39 40 were among Asians (Japan), and the
others
34 36 38 41 42 were conducted in the United States. Egg
consumption was measured by food frequency questionnaires
in all studies. Four studies
36 38 40 42 used repeated measurements
to update dietary information to more accurately reflect the
dietary intakes over follow-up. Results of study quality
assessment (score 0-9) yielded a score of 6.5 or above (high
quality) for all studies, with an average score of 7.6 (web
appendix, tables A and B).
Association between egg consumption and
risk of coronary heart disease
Six articles
34 36 37 40-42 with nine reports were included in the
dose-responseanalysisofeggconsumptionandriskofcoronary
heart disease. Using a restricted cubic splines model, we found
no evidence of a curve linear association between egg
consumption and risk of coronary heart disease (P=0.67 for
non-linearity; fig 2⇓). The summary relative risk of coronary
heart disease for an increase of one egg per day was 0.99 (95%
confidence interval 0.85 to 1.15; P=0.88 for linear trend). We
saw no heterogeneity among studies (P=0.97, I
2=0%; fig 3⇓).
Additionally, Begg and Egger regression tests provided no
evidence of substantial publication bias (P>0.05 for both tests).
Among the included studies, two articles
34 37 (four total reports)
examined the relation between egg consumption and risk of
coronary heart disease in populations with diabetes. Owing to
the lack of data for person years in diabetic populations, we
obtained the summary relative risk comparing the highest with
the lowest egg consumption for coronary heart disease in
diabeticpatients(relativerisk1.54(1.14to2.09);P=0.01;table
3⇓; web appendix, table C).
Association between egg consumption and
risk of stroke
This dose-response analysis involved six articles
34 37-39 41 42 with
eight reports on egg consumption and stroke risk. We did not
find a curve linear association between egg consumption and
risk of stroke (P=0.27 for non-linearity; fig 4⇓). The combined
relative risk of stroke for an increment of one egg consumed
perdaywas0.91(95%confidenceinterval0.81to1.02;P=0.10
for linear trend; fig 5⇓). No heterogeneity of effect estimates
on relative risks was observed (P=0.46, I
2=0%). Neither the
Begg test nor the Egger test for publication bias reached
significance (P>0.05 for both tests). In addition, three
articles
34 37 39 with four reports provided information on fatal
stroke (pooled relative risk 0.94 (0.80 to 1.10); P=0.46; table
3). Moreover, four articles
38 39 41 42 reported results for different
typesofstroke,andthreearticles
34 41 42providedresultsforstroke
in those with diabetes. For these studies, the combined relative
risks comparing the highest versus lowest egg intake were 0.75
(0.57 to 0.99) for hemorrhagic stroke, 0.91 (0.82 to 1.01) for
ischemic stroke, and 0.80 (0.29 to 2.15) for total stroke among
people with diabetes (table 3; web appendix, table D).
Subgroup analyses
Subgroup analyses were conducted to examine the stability of
the primary results (table 3). The associations between egg
consumptionandriskofcoronaryheartdiseaseandstrokewere
similar in subgroup analyses, which were defined by sex, study
location,numberofcasesorparticipants,durationoffollow-up,
repeated egg consumption measurements, study quality, and
whether diet variables or cholesterol levels were controlled for
in models. An increment of one egg consumed per day did not
significantly increase risk of coronary heart disease or stroke
in any of the categories.
Discussion
Thismeta-analysisidentifiednosignificantassociationbetween
egg consumption and risk of coronary heart disease or stroke.
Higherintakeofeggs(uptooneeggperday)wasnotassociated
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RESEARCHwith risk of coronary heart disease or stroke. Similar results
were obtained in subgroup analyses. However, among diabetic
participants, higher egg consumption was associated with a
significantly elevated risk of coronary heart disease. On the
other hand, higher egg intake was associated with a lower risk
of hemorrhagic stroke. These subgroup results should be
interpreted with caution, because only a few studies focused on
diabetic participants and particular stroke subtypes.
Results in relation to other studies
To date, the majority of prospective studies have found no
significant association between egg consumption and risk of
coronary heart disease or stroke. However, Burke and
colleagues
43 analyzed data from 514 Western Australian
aborigines with almost 14 years of follow-up and found that
risk of coronary heart disease increased in participants
consuming eggs more than twice per week. But this study was
small and analyzed multiple dietary and lifestyle exposures.
Some studies have found an inverse association between egg
consumption and stroke risk. For example, an analysis of the
Third National Health and Nutrition Examination Survey
1988-1994 (NHANES III) dataset found a significant inverse
association between higher egg consumption and stroke
mortality among men.
34 A cohort study from Japan found that
increasedconsumptionofanimalproducts(includingeggs)was
associated with reduced risk of total and hemorrhagic stroke
death.
39
Weconsideredseveralpotentialreasonsforthelackofanoverall
associationbetweeneggconsumptionandcoronaryheartdisease
or stroke. Although dietary cholesterol influences plasma
concentrations of serum cholesterol, the effects are relatively
small.
10 In addition, epidemiologic studies have found weak or
little association between dietary cholesterol intake and
cardiovascular disease risk.
10 Apart from dietary cholesterol,
saturated fat and dietary patterns might also influence blood
cholesterol levels,
44-46 suggesting that compliance with general
dietary recommendations instead of simply reducing egg
consumption could have a greater effect on the risk of
cardiovascular disease. Additionally, individual differences in
response to dietary cholesterol vary greatly, which could affect
the association between egg consumption and risk of coronary
heart disease and stroke. Moreover, several studies have shown
that egg consumption favors the formation of larger LDL and
HDL particles, which might enhance protection against
atherosclerosis.
47 48
Otherthancholesterol,eggsareagoodsourceofothernutrients
suchashighqualityproteinandvitaminD.IntheDiet,Obesity,
and Gene (Diogenes) Project, increased protein consumption
together with a modest reduction in glycemic index was
beneficial for weight control.
49 Substituting protein for
carbohydrate also partly resulted in lower blood pressure,
improved lipids levels, and concomitantly reduced
cardiovascular risk.
50 Higher vitamin D intake might have
beneficial effects on the reduction of visceral adipose tissue
51
and other cardiovascular risk factors
52.
Another possibility is that lifestyle factors associated with egg
consumptionmighthaveobscuredapositiveassociationbetween
egg consumption and risk of coronary heart disease and stroke.
However, regular egg consumption tends to be associated with
unhealthy lifestyle factors such as smoking and physical
inactivity.
34 36 53 Higher consumption of eggs is also likely to be
associated with increased consumption of red and processed
meats.
36 These confounding factors tend to exaggerate rather
than mask the association between egg consumption and
cardiovascular disease risk. One study found that participants
with high levels of cholesterol in the blood were more likely to
reduce their egg consumption than others.
40 However, our
subgroup analysis showed that the association between egg
consumption and coronary heart disease was similar in the
models, with or without adjustment for cholesterol levels.
Recently, a cross sectional study assessed the total plaque area
in patients attending Canadian vascular prevention clinics to
determine whether the atherosclerosis burden was related to
dietary egg intake.
54 The study found a strong positive
association between the number of egg yolks and the degree of
atherosclerosis measured by plaque areas. However, the study
did not assess or adjust for other dietary or lifestyle factors and
did not examine hard cardiovascular disease endpoints. The
cross sectional nature of the study also limited causal
interpretation of the data. Therefore, the results from this cross
sectional analysis should be interpreted with caution.
55 The
findings from our meta-analyses of prospective cohort studies
do not support a positive association between egg consumption
and cardiovascular disease outcomes in the general population.
Subgroup analyses have suggested a positive association
between egg consumption and coronary heart disease risk in
diabeticpatients.Amongdiabeticpopulations,decreasedplasma
levels of apolipoprotein E, together with increased levels of
apolipoprotein C-III could lead to abnormal cholesterol
transport, which might increase the risk of coronary heart
disease.
56 57 The adverse effect of egg consumption on
lipoprotein profile and glycemic control could contribute to the
elevated risk of coronary heart disease in diabetic populations.
Inaddition,insulinsensitivitycouldinfluenceHDLmetabolism
and cholesterol transport.
58 59 Riemens and colleagues
60 found
that people with lower insulin sensitivity had increased levels
of plasma cholesterol, very low density lipoprotein cholesterol,
and LDL cholesterol, compared with those with higher insulin
sensitivity. Activities of plasma lecithin, cholesterol acyl
transferase, phospholipid transfer protein, and hepatic lipase
werenegativelycorrelatedwithinsulinsensitivity,whichcould
have enhanced reverse cholesterol transport.
60 These findings
suggest a biological mechanism for possible adverse effects of
insulin resistance on risk of coronary heart disease in diabetic
populations through cholesterol metabolism. Nonetheless, this
subgroup finding of a positive association between egg
consumption and coronary heart disease risk was based on a
smallnumberofstudiesandthusneedstobereplicatedinfurther
studies.
Several prospective cohort studies showed that hemorrhagic
stroke had an inverse association with serum levels of
cholesterol.
61-64 In particular, the result of a meta-analysis
including 13 cohorts from China and Japan showed that
decreased cholesterol concentrations conferred an increased
risk of hemorrhagic stroke.
65 It has been suggested that low
cholesterol levels promote necrosis of medial muscle cells and
reduce platelet aggregability, which could lead to plasmatic
arterionecrosis and the incidence of hemorrhagic stroke.
66 67 It
is unclear whether the inverse association between egg
consumption and hemorrhagic stroke is mediated through low
levels of serum cholesterol or other mechanisms. Since this
subgroup finding was based on a small number of studies, the
results should be interpreted with caution.
Strengths and limitations
Our study has several strengths. Our meta-analysis included
prospective cohort studies with large sample size and long
duration of follow-up, which significantly increased the
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RESEARCHstatisticalpowertodetectpotentialassociations.Weinvestigated
a dose-response relation between egg consumption and risk of
coronary heart disease and stroke, allowing us to examine the
shapeofthispossibleassociation.Linearandnon-linearrelations
were also tested to quantify the associations. In addition, we
used models adjusting for most established risk factors and did
stratifiedanalysestoexplorewhethersomefactorscouldexplain
the results.
Several limitations of our study should also be acknowledged.
Firstly, errors in measurement of egg intake and other dietary
habits could have attenuated individual study results and led to
the null association between egg consumption and risk of
coronaryheartdiseaseandstroke.Allthestudiesinouranalysis
assessedeggconsumptionusingfoodfrequencyquestionnaires,
several of which have been validated with reasonable
reproducibilityandvalidityofselfreportedeggintake.However,
misreporting of intake was still inevitable.
68-70
The cooking methods of eggs and the amount of salt added to
eggs were not available in most of the included studies. The
nutrient contents of eggs could alter depending on different
cooking methods or feeding methods of chicken. In addition,
we could not uniformly quantify the size of eggs in each study.
Moreover, participants with higher egg intake consumed more
dietary cholesterol and protein but fewer carbohydrates and
were more likely to have lower levels of education than those
with lower egg intake.
34 36 Several studies adjusted for those
confounding factors. To reduce this bias, we conducted a
stratified analysis and found the results to be robust in different
strata of covariates.
Secondly, during the long follow-up, participants may have
changed their diets. However, in our meta-analysis, nearly half
the included studies updated the diet information from food
frequency questionnaires. Stratified analysis indicated that the
associations between egg consumption and risk of coronary
heart disease and stroke were similar, regardless of whether
repeated egg consumption measurements were considered.
Thirdly, some studies considered the intake of foods in which
egg was the main ingredient. However, the results suggested
that the amount of eggs estimated in other foods was relatively
smallandwasunlikelytoaffecttheaforementionedassociations.
Finally, the statistical power was limited in subgroup analyses
of diabetic patients or subtypes of stroke.
Conclusions
In summary, results from our meta-analysis do not support that
higher egg consumption is associated with elevated risk of
coronary heart disease and stroke. Subgroup analyses suggest
a positive association between higher egg intake and risk of
coronary heart disease in diabetic patients, and an inverse
association between higher egg consumption and incidence of
hemorrhagicstroke.Studieswithlargersamplesizesandlonger
follow-uptimesarewarrantedtoconfirmthesesubgroupresults.
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RESEARCHTables
Table 1| Characteristics of participants and follow-up in included studies of egg consumption in relation to risk of coronary heart disease
and stroke
Endpoints (No of cases)
Mean length
of follow-up
(years)
No of
participants
Age at
baseline
(years)
Sex of
population Country Study name
Publication
year Author
Coronary heart disease (866) 8 37 851 40-75 Male USA Health Professionals
Follow-up Study
1999 Hu et al
36
Coronary heart disease (939) 14 80 082 34-59 Female USA Nurses’ Health Study 1999 Hu et al
36
Stroke mortality (1259) 16-17 34 807 34-103 Male and
female
Japan Hiroshima/Nagasaki
Life Span Study
2003 Sauvaget et al
39
Ischemic heart disease
mortality (39), stroke
mortality (112)
14 4077 30+ Male Japan NIPPON DATA80 2004 Nakamura et al
37
Ischemic heart disease
mortality (41), stroke
mortality (107)
14 5186 30+ Female Japan NIPPON DATA80 2004 Nakamura et al
37
Coronary heart disease (462) 10.2 90 735 40-69 Male and
female
Japan Japan Public Health
Center-based
prospective study
2006 Nakamura et al
40
Coronary artery disease
(1584), stroke (655)
20 9734 25-74 Male and
female
USA NHANES-I 2007 Qureshi et al
41
Myocardial infarction (1550),
stroke (1342)
20 21 327 40-85 Male USA Physicians’ Health
Study I
2008 Djousse et al
42
Coronary heart disease
mortality (198), stroke
mortality (63)
8.8 6833 17+ Male USA NHANES III 2011 Scrafford et al
34
Coronary heart disease
mortality (168), stroke
mortality (74)
8.9 8113 17+ Female USA NHANES III 2011 Scrafford et al
34
Stroke (1397) 22 43 150 40-75 Male USA Health Professionals
Follow-Up Study
2012 Bernstein et al
38
Stroke (2633) 26 84 010 30-55 Female USA Nurses’ Health Study 2012 Bernstein et al
38
NHANES-I=First National Health and Nutrition Examination Survey; NHANES III=Third National Health and Nutrition Examination Survey; NIPPON DATA80=National
Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged, 1980.
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RESEARCHTable 2| Outcomes and covariates of included studies of egg consumption in relation to risk of coronary heart disease and stroke
Covariates in fully adjusted model Dietary category and relative risk (95% CI) Case ascertainment Endpoints Study
Age, body mass index, two year time
periods, smoking, parental history of
myocardial infarction, multivitamin
supplement use, alcohol consumption,
menopausal status and
postmenopausal hormone use
<1 egg/week, 1.0 (reference); 1, 1.06 (0.88 to 1.27);
2-4, 1.12 (0.95 to 1.33); 5-6, 0.90 (0.63 to 1.27); ≥7,
1.08 (0.79 to 1.48)
Self reported diagnosis
or confirmed by medical
records or autopsy
Coronary heart
disease
Hu et al, 1999
36
(men)
<1 egg/week, 1.0 (reference); 1, 0.82 (0.67 to 1.00);
2-4, 0.99 (0.82 to 1.18); 5-6, 0.95 (0.70 to 1.29); ≥7,
0.82 (0.60 to 1.13)
Same as above Coronary heart
disease
Hu et al, 1999
36
(women)
(women), history of hypertension,
physical activity, and total energy intake
Age, sex, birth cohort, city, radiation
dose, body mass index, smoking,
alcohol habits, education level, history
of diabetes, or hypertension
Never, 1.0 (reference); ≤1 egg/week*, 0.74 (0.55 to
1.00); 2-4 eggs/week, 0.78 (0.59 to 1.04); almost daily,
0.72 (0.54 to 0.97)
Confirmed by
nationwide family
registration system
Stroke mortality Sauvaget et al,
2003
39
Age, serum creatinine, total cholesterol,
blood glucose, body mass index, blood
pressures, use of blood pressure
lowering drugs, smoking, and alcohol
intake
Ischemic heart disease mortality: seldom, 1.18 (0.26
to 5.42); 1-2 eggs/week, 1.71 (0.78 to 3.76); 0.5
eggs/day, 1.49 (0.63 to 3.48); 1 egg/day, 1.0
(reference)
Stroke mortality: seldom, 0.93 (0.36 to 2.40); 1-2
eggs/week, 1.09 (0.69 to 1.72); 0.5 eggs/day, 1.10
Confirmed by National
Vital Statistics
Ischemic heart
disease mortality,
stroke mortality
Nakamura et al,
2004
37 (men)
(0.68 to 1.76); 1 egg/day, 1.0 (reference); ≥2 eggs/day,
0.25 (0.03 to 1.81)
Ischemic heart disease mortality: seldom, 1.42 (0.56
to 3.62); 1-2 eggs/week, 0.64 (0.28 to 1.44); 0.5
eggs/day, 0.78 (0.35 to 1.82); 1 egg/day, 1.0
(reference); ≥2 eggs/day, 1.27 (0.16 to 9.80)
Stroke mortality: seldom, 0.78 (0.35 to 1.73); 1-2
eggs/week, 0.79 (0.47 to 1.33); 0.5 eggs/day, 1.46
Same as above Ischemic heart
disease mortality,
stroke mortality
Nakamura et al,
2004
37 (women)
(0.89 to 2.4); 1 egg/day, 1.0 (reference); ≥2 eggs/day,
1.22 (0.29 to 5.17)
Age; sex; body mass index;
hypertension; diabetes; use of
cholesterol lowering drugs; smoking;
alcohol drinking; whether participants
intended to avoid cholesterol rich diets;
consumption frequencies of meat, fish,
vegetables, and fruits; and cohort effects
<1 egg/week*, 1.19 (0.86 to 1.64); 1-2 eggs/week,
1.00 (0.77 to 1.30); 3-4 eggs/week, 1.00 (0.79 to 1.26);
almost daily, 1.0 (reference)
Confirmed by medical
records, letter,
telephone or death
certificate
Coronary heart
disease
Nakamura et al,
2006
40
Age, sex, race or ethnicity, systolic blood
pressure, diabetes mellitus, serum
cholesterol, smoking, body mass index,
and educational status
Coronary artery disease: <1 egg/week, 1.0 (reference);
1-6, 1.0 (0.9 to 1.1); >6, 1.1 (0.9 to 1.3)
Stroke: <1 egg/week, 1.0 (reference); 1-6, 0.9 (0.7 to
1.0); >6, 0.9 (0.7 to 1.1)
Confirmed by medical
records or death
certificate
Coronary artery
disease, stroke
Qureshi et al,
2007
41
Age, body mass index, smoking, history
of hypertension, vitamin intake, alcohol
consumption, vegetable consumption,
breakfast cereal, physical activity,
treatment arm, atrial fibrillation, diabetes
mellitus, hypercholesterolemia, and
Myocardial infarction: <1 egg/week, 1.0 (reference);
1, 1.12 (0.96 to 1.31); 2-4, 1.16 (1.00 to 1.36); 5-6,
1.18 (0.93 to 1.49); ≥7, 0.90 (0.72 to 1.14)
Stroke: <1 egg/week, 1.0 (reference); 1, 0.96 (0.82 to
1.13); 2-4, 1.06 (0.91 to 1.24); 5-6, 1.13 (0.89 to 1.42);
≥7, 0.99 (0.80 to 1.23)
Confirmed by
physicians or medical
records
Myocardial infarction,
stroke
Djousse et al,
2008
42
parental history of premature myocardial
infarction
Age, energy, marital status, educational
status, race or ethnicity, smoking, body
mass index, waist to hip ratio, diabetes,
hypertension, and dietary variables
Coronary heart disease mortality: <1 egg/week, 1.0
(reference); 1-6, 1.26 (0.79 to 2.00); >6, 1.13 (0.61 to
2.11)
Stroke mortality: <1 egg/week, 1.0 (reference); 1-6,
1.00 (0.49 to 2.02); >6, 0.27 (0.10 to 0.73)
Not applicable Coronary heart
disease mortality,
stroke mortality
Scrafford et al,
2011
34 (men)
Coronary heart disease mortality: <1 egg/week, 1.0
(reference); 1-6, 1.12 (0.66 to 1.89); >6, 0.92 (0.27 to
3.11)
Stroke mortality: <1 egg/week, 1.0 (reference); 1-6,
0.93 (0.46 to 1.90); >6, 1.03 (0.25 to 4.22)
Not applicable Coronary heart
disease mortality,
stroke mortality
Scrafford et al,
2011
34 (women)
Age, time period, body mass index,
smoking, physical exercise, parental
history of early myocardial infarction,
menopausal status in women,
multivitamin use, vitamin E supplement
use, aspirin use at least once per week,
0.14 eggs/week†, 1.0 (reference); 0.49, 0.80 (0.66 to
0.97); 1.19, 0.88 (0.73 to 1.05); 3.01, 0.80 (0.66 to
0.96); 5.53, 0.84 (0.68 to 1.04)
Confirmed by medical
records or autopsy
report
Stroke Bernstein et al,
2012
38 (men)
0.49 eggs/week†, 1.0 (reference); 1.26, 0.90 (0.80 to
1.01); 2.17, 0.94 (0.83 to 1.05); 3.01, 0.86 (0.76 to
0.99); 4.69, 0.91 (0.80 to 1.04)
Same as above Stroke Bernstein et al,
2012
38 (women)
total energy, cereal fiber, alcohol, trans
fat, fruit and vegetables, and other
protein sources
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RESEARCHTable 2 (continued)
Covariates in fully adjusted model Dietary category and relative risk (95% CI) Case ascertainment Endpoints Study
*Unit of egg consumption was assumed.
†Servings per day converted to eggs consumed per week.
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RESEARCHTable 3| Stratified analyses of relative risk of coronary heart disease and stroke
P for test I
2 P for heterogeneity Relative risk (95% CI) No of reports*
Coronary heart disease
0.88 0.0 0.97 0.99 (0.85 to 1.15) 9 Total cases
0.53 0.0 0.91 1.18 (0.71 to 1.96) 4 Fatal cases
0.01 0.0 0.59 1.54 (1.14 to 2.09) 5 Coronary heart disease with
diabetes†
Subgroup analyses for total coronary heart disease
Sex
0.53 0.0 0.83 1.06 (0.89 to 1.25) 4 Male
0.95 0.0 0.99 0.99 (0.83 to 1.20) 3 Female
Study location
0.89 0.0 0.96 1.01 (0.90 to 1.13) 6 USA
0.79 0.0 0.76 0.95 (0.64 to 1.41) 3 Asia
No of participants
0.70 0.0 0.87 0.97 (0.81 to 1.15) 4 >10 000
0.42 0.0 0.93 1.14 (0.83 to 1.56) 5 ≤10 000
No of cases
0.94 0.0 0.79 1.00 (0.89 to 1.13) 4 >500
0.83 0.0 0.93 0.96 (0.67 to 1.37) 5 ≤500
Duration of follow-up
0.83 0.0 0.40 1.02 (0.89 to 1.16) 2 >15 years
0.85 0.0 0.98 0.98 (0.81 to 1.19) 7 ≤15 years
Repeated egg consumption measurements
0.70 0.0 0.87 0.97 (0.81 to 1.15) 4 Yes
0.42 0.0 0.93 1.14 (0.83 to 1.56) 5 No
Study quality
0.74 0.0 0.93 0.97 (0.80 to 1.17) 5 Score ≥8
0.55 0.0 0.81 1.06 (0.88 to 1.28) 4 Score <8
Controlling for other diet variables in models‡
0.73 0.0 0.97 0.97 (0.82 to 1.15) 6 Yes
0.40 0.0 0.92 1.14 (0.84 to 1.55) 5 No
Controlling for serum cholesterol levels or use of cholesterol lowering drugs in models
0.83 0.0 0.65 0.97 (0.75 to 1.26) 5 Yes
0.94 0.0 0.97 1.01 (0.86 to 1.18) 4 No
Stroke
0.10 0.0 0.46 0.91 (0.81 to 1.02) 8 Total stroke
0.46 0.0 0.47 0.94 (0.81 to 1.10) 4 Fatal stroke
0.04 36.8 0.21 0.75 (0.57 to 0.99) 3 Hemorrhagic stroke†
0.08 0.0 0.79 0.91 (0.82 to 1.01) 4 Ischemic stroke†
0.65 58.9 0.09 0.80 (0.29 to 2.15) 3 Stroke with diabetes†
Subgroup analyses for total stroke
Sex
0.13 90.5 <0.001 0.89 (0.77 to 1.03) 4 Male
0.25 29.0 0.24 0.91 (0.77 to 1.07) 4 Female
Study location
0.13 4.9 0.38 0.90 (0.79 to 1.03) 5 USA
0.34 20.6 0.28 0.94 (0.83 to 1.07) 3 Asia
No of participants
0.10 26.9 0.25 0.90 (0.80 to 1.02) 4 >10 000
0.85 0.0 0.50 0.97 (0.75 to 1.27) 4 ≤10 000
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RESEARCHTable 3 (continued)
P for test I
2 P for heterogeneity Relative risk (95% CI) No of reports*
No of cases
0.09 5.0 0.38 0.91 (0.81 to 1.02) 5 >500
0.99 4.2 0.35 1.00 (0.63 to 1.59) 3 ≤500
Duration of follow-up
0.09 5.0 0.38 0.91 (0.81 to 1.02) 5 >15 years
0.99 4.2 0.35 1.00 (0.63 to 1.59) 3 ≤15 years
Repeated egg consumption measurements
0.14 51.5 0.13 0.90 (0.78 to 1.04) 3 Yes
0.38 0.0 0.64 0.94 (0.83 to 1.08) 5 No
Study quality
0.71 0.0 0.51 1.03 (0.88 to 1.20) 5 Score ≥7.5
0.07 0.0 0.82 0.88 (0.77 to 1.01) 3 Score <7.5
Controlling for other diet variables in models‡
0.14 26.6 0.25 0.90 (0.79 to 1.04) 4 Yes
0.43 0.0 0.62 0.95 (0.83 to 1.08) 5 No
Controlling for serum cholesterol levels or use of cholesterol lowering drugs in models
0.60 10.0 0.34 1.04 (0.91 to 1.18) 4 Yes
0.07 0.0 0.94 0.89 (0.77 to 1.01) 4 No
*Five articles reported their results by sex group; therefore, there were nine reports from six articles for coronary heart disease and eight reports from six articles
for stroke.
†Owing to a lack of data for person years, results are relative risks (95% confidence intervals) comparing highest with lowest egg consumption.
‡Study by Scrafford and colleagues reported results both controlling for diet variables and not.
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RESEARCHFigures
Fig 1 Flow diagram of literature search and study selection
Fig 2 Dose-response analyses of egg consumption and risk of coronary heart disease
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RESEARCHFig 3 Forest plot of egg consumption and risk of coronary heart disease
Fig 4 Dose-response analyses of egg consumption and risk of stroke
Fig 5 Forest plot of egg consumption and risk of stroke
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